Keeping Atherosclerosis in-check with Novel Targeted Nanomedicines

Keeping Atherosclerosis in-check with Novel Targeted Nanomedicines

Furthermore, this peptide was derived from one of the body's own natural anti-inflammatory proteins called Annexin A1. The way the nanomedicines were designed enabled this biological therapeutic to be released at the target site, the atherosclerotic

(Visited 15 times, 1 visits today)
9
Like
Save

Comments

Comments are disabled for this post.